title: [A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
abstract: The patient was a 60-year-old women who had undergone left modified radical mastectomy on April 7, 1999, and was treated with chemo- and hormonal therapy of UFT and TAM. Two years and 6 months later, she showed multiple lung metastases. Because 5'-DFUR + MPA therapy was not effective, weekly docetaxel (TXT) + adriamycin (ADM) was carried out, and definite improvement in the lung and lymph nodes metastases was observed. It is suggested that this combination therapy may be useful for advanced recurrent breast cancer patients with multiple lung metastases.
authors.affiliation: Dept. of Surgery, Hirosaki Central Hospital.
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Sawada
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Ono
authors.forename: Matsuro
authors.initials: M
authors.lastname: Fukushima
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D003131:Combined Modality Therapy; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008207:Lymphatic Metastasis; D015411:Mastectomy, Modified Radical; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives*; D012878:Skin Neoplasms / Q000556:secondary; D043823:Taxoids
chemical_list: D043823:Taxoids; D005467:Floxuridine; D000077143:Docetaxel; D004317:Doxorubicin; D017258:Medroxyprogesterone Acetate; D017239:Paclitaxel; C025034:doxifluridine